首页 > 期刊杂志 > 正文

Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.

肝细胞分化标志物在胰腺腺泡细胞肿瘤中的表达:潜在的诊断缺陷

Askan G,Deshpande V,Klimstra DS,Adsay V,Sigel C,Shia J,Basturk O

Abstract

Pancreatic acinar cell carcinoma (ACC) is a rare tumor that frequently metastasizes to the liver and may present a diagnostic challenge due to its morphologic similarity to hepatocellular carcinoma. We investigated α-fetoprotein (AFP), hepatocyte paraffin antigen 1 (HepPar 1), glypican 3, arginase 1, and albumin messenger RNA (mRNA) in situ hybridization (ISH) in pancreatic neoplasms with ACC differentiation to assess their diagnostic value.
AFP, HepPar 1, glypican 3, and arginase 1 immunohistochemical staining was performed on 28 ACCs using a tissue microarray. Albumin mRNA ISH was performed on full-faced sections.
Fifteen tumors were positive for at least one marker. Glypican 3 was positive in seven of 28, AFP in five 28, and albumin mRNA ISH in five of 20. None expressed arginase 1.
Hepatocellular differentiation markers, including albumin mRNA ISH, may be positive in ACC, but arginase 1 appears to be uniformly negative. Thus, its use may improve the accuracy in distinguishing these neoplasms from hepatocellular carcinoma. If ACC diagnosis is considered, acinar differentiation can be reliably demonstrated by trypsin/chymotrypsin.

摘要

胰腺腺泡细胞癌(ACC)是一种罕见肿瘤,经常转移到肝脏,且由于其形态学上与肝细胞癌相似而常造成诊断难题。 我们在具有ACC分化的胰腺肿瘤组织中研究甲胎蛋白(AFP)、肝细胞石蜡抗原1(HepPar 1)、磷脂酰肌醇蛋白聚糖3、精氨酸酶1以及白蛋白信使RNA(mRNA)原位杂交,从而评估这些标志物的诊断价值。

使用组织微阵列对28个胰腺腺泡细胞癌组织进行AFP、HepPar 1、磷脂酰肌醇蛋白聚糖3和精氨酸酶1的免疫组织化学染色。白蛋白mRNA则进行原位杂交分析。

15例肿瘤组织中至少对一种标志物呈阳性反应。28例组织中,磷脂酰肌醇蛋白聚糖3显阳性的有7例,AFP显阳性的有5例;20例组织中,白蛋白mRNA 原位杂交分析阳性的有5例。精氨酸酶1染色结果均为阴性。

肝细胞分化标志物、包括白蛋白mRNA原位杂交,在ACC中可以是阳性的,但精氨酸酶1似乎均为阴性。基于此,可以更准确地与肝细胞癌加以区分。 如果考虑ACC诊断,可以比较可靠地通过胰蛋白酶/胰凝乳蛋白酶证明腺泡分化。

full text

我要评论

0条评论